The EQIPD project was presented at the PreNeuroscience 2018 Seminar and Networking event that took place on 2 November 2018 in
conjunction with the Society for Neuroscience’s (SfN) annual meeting in San Diego, California, USA, to create awareness in the USA as well – Download our 2nd newsletter to see more updates and news!
In the newest edition of the newsletter, find out more about the highlights of the EQIPD General Assembly meeting, the new project collaborations, CAMARADES winning the BNA’s ‘Credibility Prize’ and details on the 34th ECNP congress. Read the Newsletter here.
The Guarantors of EQIPD and PAASP Network are delighted to announce the launch of a joint effort to promote the EQIPD framework, to deliver and to further develop the EQIPD Quality System. We very much look forward to this next stage in the EQIPD journey.
The need for quality standards in preclinical research is gaining attention, especially in translational research. The IMI-PainCare consortium has reached out to EQIPD to collaborate in assessing the study design and data analysis for their studies in the BioPain and TRiPP groups. This collaboration will ensure equivalent quality standards in preclinical research among their project…
On October 10, 2022, #EQIPD will lead a discussion on how to help funders and grant applicants align on research rigor expectations and avoid funding of research of unknown quality. Objectives of the meeting are to: Review lessons learned from the US and German publicly funded programs that focused directly or indirectly on decision-enabling research…
The Guarantors of EQIPD (GoEQIPD) is a not-for-profit society established to oversee the implementation of the EQIPD Quality System (QS). We are seeking proposals from organisations who wish to work with us in providing mentoring and accreditation to laboratories wishing to meet EQIPD QS standards. Read about the EQIPD QS in our eLife publication Read…
Check out the updates on the outcome of the Alzheimer systematic review, the EQIPD brainstorming session at ECNP, and more in the newest version of our newsletter! Read the Newsletter here.